Back
Grand Canyon Education Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
62
LOPE
Grand Canyon Education
Last Price:
145.02
Seasonality Move:
2.86%
Buy
62
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
45.76
Seasonality Move:
-8.14%
Buy
62
Grand Canyon Education (LOPE)
is a Buy
Is Grand Canyon Education a Buy, Sell or Hold?
- The current Grand Canyon Education [LOPE] share price is $144.75. The Score for LOPE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- LOPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $44.14. The Score for CRBP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LOPE Stock Price Chart
What is Grand Canyon Education's stock price today?
-
The Grand Canyon Education share price today is $144.75
The current trend is moderately bullish and LOPE is experiencing slight buying pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $44.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight selling pressure.
LOPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.93 | Buy |
Relative Strength Index (14 RSI): | 65.97 | Buy |
Chaikin Money Flow: | 34918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.21 - 142.45) | Buy |
Bollinger Bands (100): | (127.03 - 137.93) | Buy |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.63 | Buy |
Relative Strength Index (14 RSI): | 64.96 | Buy |
Chaikin Money Flow: | -124400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.22 - 42.24) | Buy |
Bollinger Bands (100): | (14.78 - 41.78) | Buy |
LOPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 144.92 | Sell |
20-day SMA: | 136.46 | Buy |
50-day SMA: | 134.43 | Buy |
200-day SMA: | 127.35 | Buy |
8-day EMA: | 143.79 | Buy |
20-day EMA: | 139.2 | Buy |
50-day EMA: | 135.5 | Buy |
200-day EMA: | 127.64 | Buy |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.2 | Buy |
20-day SMA: | 38.94 | Buy |
50-day SMA: | 39.41 | Buy |
200-day SMA: | 17.1 | Buy |
8-day EMA: | 42.17 | Buy |
20-day EMA: | 40.25 | Buy |
50-day EMA: | 36.89 | Buy |
200-day EMA: | 22.3 | Buy |
Grand Canyon Education Earnings Growth & LOPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.86 per share, and an increase next year of $0.85 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.
Grand Canyon Education Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |